These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Is endoscopic balloon dilation for removal of bile duct stones associated with an increased risk for pancreatitis or a higher rate of hyperamylasemia? Bergman JJ; van Berkel AM; Bruno MJ; Fockens P; Rauws EA; Tijssen JG; Tytgat GN; Huibregtse K Endoscopy; 2001 May; 33(5):416-20. PubMed ID: 11396759 [TBL] [Abstract][Full Text] [Related]
25. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results. Poon RT; Fan ST JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study. Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632 [TBL] [Abstract][Full Text] [Related]
33. Preventing post-ERCP pancreatitis: where are we? Testoni PA JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013 [TBL] [Abstract][Full Text] [Related]
34. Neutrophil activation and hyperamylasaemia after endoscopic retrograde cholangiopancreatography: potential role for the leukocyte in the pathogenesis of acute pancreatitis. Mann DV; Kalu P; Foulds S; Edwards R; Glazer G Endoscopy; 2001 May; 33(5):448-53. PubMed ID: 11396766 [TBL] [Abstract][Full Text] [Related]
35. Determination of elastase-1 serum levels in post ERCP/EST pancreatic damage. Hardt PD; Fadgyas T; Kress O; Doppl WE; Weber HP; Bimler EA; Temme H; Klör HU Z Gastroenterol; 1999 Aug; 37(8):701-5. PubMed ID: 10494604 [TBL] [Abstract][Full Text] [Related]
36. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. Khoshbaten M; Khorram H; Madad L; Ehsani Ardakani MJ; Farzin H; Zali MR J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e11-6. PubMed ID: 17683501 [TBL] [Abstract][Full Text] [Related]
37. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis. Masci E; Cavallini G; Mariani A; Frulloni L; Testoni PA; Curioni S; Tittobello A; Uomo G; Costamagna G; Zambelli S; Macarri G; Innocenti P; Dragonetti C; Am J Gastroenterol; 2003 Oct; 98(10):2182-6. PubMed ID: 14572565 [TBL] [Abstract][Full Text] [Related]
38. Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination? Pezzilli R; Gabbrielli A; Labate AM; D'Alessio P; Barakat B; Costamagna G; Dibenedetti F; Massa M; Merlini G; d'Eril GM Hepatogastroenterology; 2003; 50(51):851-5. PubMed ID: 12828103 [TBL] [Abstract][Full Text] [Related]
39. Early endoscopic cholangiopancreatography and sphincterotomy in acute biliary pancreatitis: report of 50 cases. Uomo G; Galloro V; Rabitti PG; Marcopido B; Laccetti M; Visconti M Ital J Gastroenterol; 1991 Dec; 23(9):564-6. PubMed ID: 1760564 [TBL] [Abstract][Full Text] [Related]
40. Risk factors for pancreatitis after pancreatic sphincterotomy: a review of 572 cases. Hookey LC; RioTinto R; Delhaye M; Baize M; Le Moine O; Devière J Endoscopy; 2006 Jul; 38(7):670-6. PubMed ID: 16810591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]